Science news articles about 'william hahn'

... be identified," remarked the study's senior author, William Hahn, MD, PhD, of Dana-Farber and ... CDK8 protein and overactive beta-catenin," Hahn said. "Drugs that target CDK8 may be very useful against ...

... a real frustration," said Gary Gilliland of Harvard Medical School, who led one of the studies with his colleague William Hahn. "We know the mutation, but we haven't been able to do a thing about it." ...

... gene. "These results represent a new way of targeting oncogenes that have been refractory to standard treatments," said William Hahn, MD, PhD, senior author of the report, of Dana-Farber, the Broad ...